| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/17/2005 | US20050037415 Using transgenic cells as tools in identifying therapeutic amino acids; mimetic peptides; drug screening |
| 02/17/2005 | US20050037414 Nucleotide sequences specific to hepatitis B viral genome for use as amplification tool in detection of viral infection |
| 02/17/2005 | US20050037413 functionalized substrates bound to layers of dendrimers and to target-specific ligands, used in combinatorial chemistry, protein, nucleic acid or nucleic acid/peptide hybridization detection; medical diagnosis |
| 02/17/2005 | US20050037412 Thermostable Taq polymerase fragment |
| 02/17/2005 | US20050037410 Detection format for hot start real time polymerase chain reaction |
| 02/17/2005 | US20050037409 Identifying and quantifying fusion protein comprising translocating markers that are responsive to altered cellular conditions; detecting vector transformed cell |
| 02/17/2005 | US20050037408 Rapid identification of bacteria from positive blood cultures |
| 02/17/2005 | US20050037406 Using fluorescent microscopy to detect, quantify and characterize cells associated with cell proliferative disorders; image diagnostics and cancer detection |
| 02/17/2005 | US20050037405 Method for assessing behavioral predisposition |
| 02/17/2005 | US20050037404 Methods of modulating drug clearance mechanisms by altering SXR activity |
| 02/17/2005 | US20050037403 Immunomodulatory oligonucleotides |
| 02/17/2005 | US20050037402 Device and process for direct quantitative in vitro determination of a substance that is contained in a sample |
| 02/17/2005 | US20050037400 Identifying non-human primate genomic sequences associated with enhanced protection from viral infection viral; enhancing resistance lymphadenopathy associated viral infection |
| 02/17/2005 | US20050037399 nucleic acid having a specific nucleotide sequence, used to diagnose or determine predisposition to adenocarcinoma. |
| 02/17/2005 | US20050037398 2'-terminator nucleotide-related methods and systems |
| 02/17/2005 | US20050037397 Bio-barcode based detection of target analytes |
| 02/17/2005 | US20050037396 compounds for analyzing primer extension products incorporating universal bases; microsatellite analysis |
| 02/17/2005 | US20050037394 preparing transcription reaction mixture comprising mutated polymerase, modified nucleotide triphosphates (NTPs), magnesium ions and oligonucleotide templates, partitioning high affinity nucleic acids, then replicating; point mutations; increased stability and half life |
| 02/17/2005 | US20050037393 used to genotype individuals on a genome-wide scale; simultaneously detecting large numbers of typable loci for an amplified representative population of genome fragments using genetic probes having sequences corresponding to the typable loci |
| 02/17/2005 | US20050037392 Optical sorting method |
| 02/17/2005 | US20050037391 Polypeptide |
| 02/17/2005 | US20050037390 Exposing transgenic cell comprising vectors which contain erythropoietin regulator sequences and reporter molecules to erythropoietin modulating protein, monitoring gene expression; identifying agents for treatment of blood disorders |
| 02/17/2005 | US20050037389 Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors |
| 02/17/2005 | US20050037388 Method for detecting diseases caused by chromosomal imbalances |
| 02/17/2005 | US20050037387 Modulation of the RNA interference pathway |
| 02/17/2005 | US20050037385 Genetically engineered protein comprising multiple zinc finger domains for use as regulatory quadruplets in gene expression analysis |
| 02/17/2005 | US20050037382 Methods and compositions for treating and preventing autoimmune disorders |
| 02/17/2005 | US20050037381 Artificial receptors, building blocks, and methods |
| 02/17/2005 | US20050037379 Reagents and methods useful for detecting diseases of the prostate |
| 02/17/2005 | US20050037376 Sulfatase polypeptide for use in treatment and prevention of microbial infection, cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/17/2005 | US20050037375 Using ligand-receptor interactions as tool to monitor effectiveness of modulators in disease treatment which act via receptor binding; drug screening and design |
| 02/17/2005 | US20050037373 Detection of preferential chromosomal rearrangement in sample; extract nucleotide sequences from sample, determine concentration, reverse transcribe, detect leukemic cells; for monitoring response to therapy |
| 02/17/2005 | US20050037371 Computer hybridization analysis of preferential gene sequences; genomics |
| 02/17/2005 | US20050037370 RNA-induced silencing complexes; RNA interference; gene expression inhibition |
| 02/17/2005 | US20050037369 Using cell surface and lymphocyte receptors to identify modulator for use in treatment and prevention of graft rejection and cell proliferative disorders; peptide mimetics; imaging diagnostics |
| 02/17/2005 | US20050037367 Apparatus comprising microarray of nucleic acid probes fabricated at known locations for use in imaging nucleic acid hybridization |
| 02/17/2005 | US20050037366 Individual drug safety |
| 02/17/2005 | US20050037364 Techniques for recording signals |
| 02/17/2005 | US20050037363 Methods and system for multi-drug treatment discovery |
| 02/17/2005 | US20050037362 Using microarray hybridization to quantify and analyze RNA interference; detection, identification and/or quantification of multiple gene-specific short interfering RNA sequences |
| 02/17/2005 | US20050037361 Kit comprising betaine and sorbitol additives for use in decreasing stalling during replication of mononucleotide, dinucleotide, tetranucleotide and pentanucleotide microsatellite sequences; genotyping |
| 02/17/2005 | US20050037358 Converting immunoglobulin variable domain messenger RNA into CDNA using univversal primer, amplifying, inserting and replicating nucleotide sequences in vector and host cells; immunotherapy |
| 02/17/2005 | US20050037357 Matrix comprising immobilized polynucleotide probes for use in determining translation efficiency of messenger RNA variants and monitor accuracy gene expression in cells |
| 02/17/2005 | US20050037356 Nucleic acid enrichment |
| 02/17/2005 | US20050037355 Measuring intracellular adenosine triphosphate and/or gene expression in transgenic cell via monitoring luciferin bioluminescent signals; genetiic engineering and reporter molecules |
| 02/17/2005 | US20050037354 Method for epigenetic knowledge generation |
| 02/17/2005 | US20050037353 Highly sensitive methods for protein detection in proteomics |
| 02/17/2005 | US20050037352 Assay |
| 02/17/2005 | US20050037351 Method of purifiying nucleic acid using nonwoven fabric and detection method |
| 02/17/2005 | US20050037350 Using molecular marker and restriction fragment length polymorphism in qualitative gene loci to identify and fingerprint tree species comprising genotype capable of manifesting preferential phenotype |
| 02/17/2005 | US20050037349 Method for the preparation of reagents for amplification and/or detection of nucleic acids that exhibit no significant contamination by nucleic acids |
| 02/17/2005 | US20050037346 Distinguish minority template in the presence of an excess of normal template with a thermostable ligase; useful for the detection of cancer-associated mutations; quantitative measure of the amount or ratio of minority template; a thermostable mutant ligase |
| 02/17/2005 | US20050037345 Gene with polynucleopotide codes with polypeptide with amino acid sequences for domains and molecular hybridization for gene expression and cancer |
| 02/17/2005 | US20050037344 Nucleic acid array |
| 02/17/2005 | US20050037340 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics |
| 02/17/2005 | US20050037339 Methods of selecting internalizing antibodies |
| 02/17/2005 | US20050037338 Method and means for detection of severe acute respiratory syndrome |
| 02/17/2005 | US20050037336 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 02/17/2005 | US20050037335 Method for identifying novel transcriptional regulatory proteins |
| 02/17/2005 | US20050037334 Method of determining sperm capacitation |
| 02/17/2005 | US20050037088 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/17/2005 | US20050037011 Associated with a reduction in wingless-related MMTV integration site 5a (Wnt5a) gene expression or activity or protein activity; assessing the level of expression of cyclin D1 or phosphorylation of protein kinase C, calmodulin kinase II, dishevelled, or LEF-1; leukemias, lymphomas, and myelomas |
| 02/17/2005 | US20050037010 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 02/17/2005 | US20050037009 Methods and reagents for protease inhibition |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050036997 Molecular modeling of the binding sites for anisomycin, azithromycin, erythromycin, linezolid, tylosin, carbomycin A, spiramycin, virginiamycin, sparsomycin and blasticidin using the Haloarcular marismortui large ribosomal subunit; drug design and drug screening |
| 02/17/2005 | US20050036992 Novel use of liver X receptor agonists |
| 02/17/2005 | US20050036920 comprising dispensing pins including drop ejection nozzles, filling channels, reservoirs and holders containing control circuits for activators |
| 02/17/2005 | US20050034989 Mixture of gel mincing tube and mesh; dividing; centrifuging; drawing through porous material |
| 02/17/2005 | DE10335114A1 Verfahren und Kit zur Bestimmung der metabolischen Stabilität von Testsubstanzen A method and kit for determining the metabolic stability of the test substances |
| 02/17/2005 | DE10332854A1 Verwendung des neu-identifizierten humanen Gens 7a5/Prognostin für Tumordiagnostik und Tumortherapie Using the newly-identified human gene 7a5 / Prognostin for tumor diagnosis and tumor therapy |
| 02/17/2005 | DE10332848A1 Mikroarrays immobilisierter Biomoleküle, deren Herstellung und Verwendung Microarrays of immobilized biomolecules, their preparation and use |
| 02/17/2005 | DE10149684B4 Vorrichtung zur Halterung eines Substanzbibliothekenträgers A device for holding a substance library support |
| 02/17/2005 | CA2827128A1 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 02/17/2005 | CA2555323A1 Polypeptide specific to liver cancer, polynucleotide coding for the polypeptide, and rna molecule suppressing expression of the polypeptide |
| 02/17/2005 | CA2537555A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | CA2534909A1 P16 mediated regulation of nmda receptors |
| 02/17/2005 | CA2534899A1 Polypeptides having brain-localizing activity and uses thereof |
| 02/17/2005 | CA2534812A1 Mutations in ion channels |
| 02/17/2005 | CA2534739A1 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 02/17/2005 | CA2534661A1 Osteoarthritis biomarkers and uses thereof |
| 02/17/2005 | CA2534365A1 Diagnostic and therapeutics for osteoporosis |
| 02/17/2005 | CA2534296A1 Methods and compositions for targeted cleavage and recombination |
| 02/17/2005 | CA2533550A1 Antigen delivery system |
| 02/17/2005 | CA2532795A1 Sense antiviral compound and method for treating ssrna viral infection |
| 02/17/2005 | CA2532711A1 Coating of porous, surface functionalized, superparamagnetic crystal-containing polymer particles with polyisocyanate/diol and/or epoxide monomers |
| 02/17/2005 | CA2531916A1 Animal model for the analysis of tumor metastasis |
| 02/17/2005 | CA2531501A1 Reagents, methods and kits for detecting feed enzymes |
| 02/17/2005 | CA2531119A1 Qtl "mapping as-you-go" |
| 02/17/2005 | CA2528606A1 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 02/17/2005 | CA2528025A1 Nucleic acid arrays for detecting multiple strains of a non-viral species |
| 02/17/2005 | CA2526900A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | CA2526274A1 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 02/16/2005 | EP1507146A1 Bioassay method, bioassay device, and bioassay substrate |
| 02/16/2005 | EP1507011A1 PCR primer set for detecting hepatitis B virus, method for detecting hepatitis b using the primer set, and hepatitis b virus detection kit including the primer set |
| 02/16/2005 | EP1507010A2 Control of the gene expression in eukaryotic cells |
| 02/16/2005 | EP1507007A1 Cell cycle related proteins |
| 02/16/2005 | EP1507002A2 Thermostable Taq polymerase fragment |
| 02/16/2005 | EP1507000A2 A thermostable ligase mediated DNA amplification system for the detection of genetic diseases |
| 02/16/2005 | EP1506998A1 An in vitro tumor angiogenesis model |